ProShares S&P 500 ex-Health Care ETF (SPXV) Performance
SPXV total return
Distributions reinvested · as of Oct 23, 2026- YTD
- +11.6% since Dec 31, 2025
- 1 year
- +13.3% total return
- 5 years
- +12.9% a year
- 10 years
- +15.7% a year
- Since first price
- +15.6% a year since 2015
SPXV trailing returns vs SPY, QQQ, AGG
| Period | SPXV total return | Price only | S&P 500 (SPY) | Nasdaq-100 (QQQ) | U.S. bonds (AGG) |
|---|---|---|---|---|---|
| 1 month | −1.7% | −1.7% | −1.0% | −5.0% | +0.9% |
| 3 months | +2.4% | +2.2% | +3.2% | +1.9% | −0.4% |
| 6 months | +6.3% | +5.8% | +7.8% | +8.4% | −1.5% |
| YTD | +11.6% | +10.8% | +12.3% | +15.1% | −1.0% |
| 1 year | +13.3% | +12.2% | +14.4% | +15.9% | −1.1% |
| 3 years | +93.4%+24.6%/yr | +87.0% | +87.4%+23.3%/yr | +101.4%+26.3%/yr | +16.6%+5.2%/yr |
| 5 years | +83.7%+12.9%/yr | +72.6% | +79.3%+12.4%/yr | +94.0%+14.2%/yr | −0.8%−0.2%/yr |
| 10 years | +328.9%+15.7%/yr | +269.6% | +315.9%+15.3%/yr | +538.9%+20.4%/yr | +14.0%+1.3%/yr |
| Since inceptionSep 24, 2015 | +396.9%+15.6%/yr | +316.0% | — | — | — |
Total return from adjusted closes (distributions reinvested, before tax). Periods of 3 years or more are also shown annualized. Price only excludes distributions.
Growth of $10,000: SPXV vs SPY
From Sep 24, 2015: SPXV grew to $49,695, SPY to $47,126.
Year-end values with distributions reinvested, no taxes or trading costs. Start: first common trading day of both funds.
SPXV returns by calendar year
8 of 10 full years positive. Best 2019 (+33.6%), worst 2022 (−20.5%). 2026 is year to date.
SPXV annual returns table
| Year | SPXV | Largest drop | SPY | QQQ | AGG |
|---|---|---|---|---|---|
| 2026YTD | +11.6% | −9.2% | +12.3% | +15.1% | −1.0% |
| 2025 | +18.4% | −19.9% | +17.7% | +20.8% | +7.2% |
| 2024 | +28.0% | −9.4% | +24.9% | +25.6% | +1.3% |
| 2023 | +30.7% | −10.2% | +26.2% | +54.9% | +5.7% |
| 2022 | −20.5% | −26.6% | −18.2% | −32.6% | −13.0% |
| 2021 | +28.4% | −4.7% | +28.7% | +27.4% | −1.8% |
| 2020 | +19.0% | −34.3% | +18.3% | +48.6% | +7.5% |
| 2019 | +33.6% | −7.4% | +31.2% | +39.0% | +8.5% |
| 2018 | −3.8% | −19.2% | −4.6% | −0.1% | +0.1% |
| 2017 | +17.0% | −2.3% | +21.7% | +32.7% | +3.6% |
| 2016 | +13.7% | −5.3% | +12.0% | +7.1% | +2.4% |
Largest drop = deepest fall from a high within that calendar year.
Calendar-year return vs largest drop within the year
Most years include a sizable fall at some point even when the year ends higher.
SPXV largest drawdowns
Now 3.4% below the high| Peak | Decline | Bottom | Recovered | Fall | Underwater |
|---|---|---|---|---|---|
| Feb 19, 2020 | −34.3% | Mar 23, 2020 | Aug 12, 2020 | 33 days | 6 months |
| Jan 4, 2022 | −26.6% | Oct 14, 2022 | Dec 13, 2023 | 9 months | 1.9 years |
| Feb 19, 2025 | −19.9% | Apr 8, 2025 | Jun 24, 2025 | 48 days | 4 months |
| Sep 4, 2018 | −19.2% | Dec 24, 2018 | Apr 3, 2019 | 4 months | 7 months |
| Dec 2, 2015 | −11.7% | Jan 15, 2016 | Aug 1, 2016 | 44 days | 8 months |
| Sep 2, 2020 | −10.1% | Sep 23, 2020 | Nov 16, 2020 | 21 days | 2 months |
Declines from a closing high (distributions reinvested) of 10% or more. Underwater = time from the peak until the old high was regained.
SPXV risk statistics
| Statistic | 3 years | 5 years | 10 years | Since 2015 |
|---|---|---|---|---|
| Annualized return | +24.4% | +14.5% | +15.7% | +16.5% |
| Volatility (annualized) | 13.3% | 16.7% | 16.2% | 16.4% |
| Sharpe ratio | 1.40 | 0.68 | 0.85 | 0.89 |
| Sortino ratio | 3.09 | 1.10 | 1.36 | 1.46 |
| Best month | +11.7% | +11.7% | +12.9% | +12.9% |
| Worst month | −6.0% | −10.4% | −13.0% | −13.0% |
| Best 12 months | +40.8% | +40.8% | +60.0% | +60.0% |
| Worst 12 months | +9.2% | −20.5% | −20.5% | −20.5% |
| Positive months | 64% | 60% | 66% | 65% |
| Beta vs S&P 500 | 1.06 | 1.06 | 1.03 | — |
| Correlation with S&P 500 | 0.99 | 0.99 | 0.98 | — |
From monthly total returns. Sharpe and Sortino use 1–3 month T-bills (BIL) as the risk-free rate, so they need history from 2007 on.
SPXV rolling returns
| Holding period | Periods | Worst | Median | Best | Positive |
|---|---|---|---|---|---|
| 1-year | 117 | −20.5% | +18.4% | +60.0% | 86% |
| 3-year (a year) | 93 | +4.4% | +14.2% | +27.4% | 100% |
| 5-year (a year) | 69 | +9.1% | +15.2% | +20.8% | 100% |
| 10-year (a year) | 9 | +14.6% | +16.1% | +17.2% | 100% |
Every holding period starting at a month-end since 2015. Returns for 3 years and longer are annualized.
SPXV performance overview
ProShares S&P 500 ex-Health Care ETF (SPXV) returned +13.3% over the past year and +15.7% a year over ten years, with distributions reinvested. Since its first recorded price in 2015 it has returned +15.6% a year, turning $10,000 into about $49,695. Over the same year S&P 500 (SPY) returned +14.4%.
The deepest decline was −34.3%, from Feb 19, 2020 to Mar 23, 2020, and it took 5 months to get back to the old high. SPXV finished 8 of its 10 full calendar years with a gain; the best year was 2019 (+33.6%) and the worst 2022 (−20.5%). Volatility has been 16.4% a year.
Related: SPXV chart, SPXV holdings, SPXV dividends, SPXV valuation. See the SPXV overview for the latest quote and fund facts.
SPXV performance FAQ
What is the SPXV return over the past year?
SPXV returned +13.3% over the 12 months to October 23, 2026, including reinvested distributions. On price alone it rose 12.2%.
What is the average annual return of SPXV?
SPXV has returned +12.9% a year over 5 years, +15.7% a year over 10 years, +15.6% a year since September 24, 2015 (total return, distributions reinvested).
How much would $10,000 invested in SPXV be worth?
$10,000 invested in SPXV at its first recorded close on September 24, 2015 would be worth about $49,695 on October 23, 2026 with distributions reinvested.
What was the worst year for SPXV?
The worst calendar year was 2022, with a total return of −20.5%. The best was 2019 at +33.6%.
What is the biggest drawdown of SPXV?
The largest peak-to-trough decline was −34.3% between February 19, 2020 and March 23, 2020. It recovered to the old high on August 12, 2020, 5 months after the bottom.
How volatile is SPXV?
Over the past 3 years SPXV had an annualized volatility of 13.3% and a Sharpe ratio of 1.40 (excess return over 1–3 month T-bills per unit of risk).